![Quiver Logo](/static/img/logo-icon.png)
![CVRX logo](https://quiver-logos.s3.us-east-2.amazonaws.com/cvrx.png)
CVRx, Inc. Common Stock
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CVRX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of CVRX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CVRX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to CVRX
Recent picks made for CVRX stock on CNBC
ETFs with the largest estimated holdings in CVRX
Flights by private jets registered to CVRX
![Quiver Logo](/static/img/logo-icon.png)